期刊文献+

γ-分泌酶抑制剂对糖基化终产物作用下心肌微血管内皮细胞的影响

The Effects of DAPT Under Advanced Glycation End Products on Microvascular Endothelial Cells
原文传递
导出
摘要 目的:探讨Notch信号特异性阻断剂γ-分泌酶抑制剂(DAPT)对AGEs作用下的心肌微血管内皮细胞的增殖、迁移、管样结构的影响。方法:SD大鼠心肌微血管内皮细胞体外分离培养后,以不同浓度DAPT(0.25、0.5、1.0、5.0、10μmol/L)干预200mg/LAGEs作用下的CMECs24h,或者与DAPT(5μmol/L)孵育不同时间(24h、48h、72h、96h、120h),采用MTT比色法检测细胞的增值能力;用Transwell法检测细胞的迁移能力;用毛细血管管样结构形成实验检测DAPT对血管新生的影响。结果:DAPT显著抑制AGEs作用下的心肌微血管内皮细胞的存活,同时浓度越高、时间越长,其抑制效果越明显。结论:DAPT通过阻断Notch信号通路,能抑制AGEs作用下的心肌微血管内皮细胞的增殖及血管新生,促进细胞凋亡。 Objective:To investigate the effect of DAPT under the advanced glycation end products(AGEs) on proliferation,migration,angiogenesis and lumen formation of cardiac microvascular endothelial cells(CMECs).Methods: CMECs isolated from the hearts of adult rats were exposed to hypoxia(94%N2,5%CO2,1%O2).The cells were incubated with different concentrations(in μmol/L:0,0.25,0.5,1.0,5.0,10.0) of DAPT for 24h,or incubated with DAPT(5 μ mol/L) for 24h,48h,72h,96h and 120h.The cell viability of CMECs was measured by MTT method and migration ability of CMECs was detected by Tranwell method.Capillary lumen formation test was applied to detect the angiogenesis.Results: The viability of CMECs depressed with DAPT incubation.Conclusion: DAPT can interrupt the transduction of Notch signaling pathway in cardiac microvascular endothelial cells(CMECs) and inhibit the viability of the cells and increase their apoptosis.
出处 《现代生物医学进展》 CAS 2012年第7期1229-1232,共4页 Progress in Modern Biomedicine
基金 陕西省科学技术研究发展计划项目(2010K16-04-03)
关键词 AGES 心肌微血管内皮细胞 DAPT NOTCH 管样结构 AGEs CEMCs DAPT Notch Tube formation
  • 相关文献

参考文献17

  • 1Peppa M,Uribarri J,Vlassara H.The role of advanced glycation endproducts in the development of atherosclerosis[J].Curr Diabed Rep,2004,4(1):31-36
  • 2Luttun A,Carmeliet G,Carmeliet P.Vascular progenitors:from biol-ogy to treatment[J].Trends Cardiovasc Med,2002,12(2):88-96
  • 3Liu Z,Li Y,Kong Q,et al.Immunohistochemical profiling of Wnt,NF-κB,Stat3 and Notch signaling in human epidermal tumors[J].JDermatol Sci,2008,52(2):133-136
  • 4Staton CA,Stribbling SM,Tazzyman S,et a1.Current methods assaying angiogenes is in vitro and in vivo[J].Int J Exp Pathol,2004,85(5):233-248
  • 5Nemir M,Pedrazzini T.Functional role of Notch signaling in thedeveloping and postnatal heart[J].J Mol Cell Cardiol,2008,45(4):495-504
  • 6Huijberts MS,Schaper NC,Schalkwijk CG.Advanced glycation endproducts and diabetic foot disease[J].Diabetse Metab Res Rev,2008,24(1):S19-S24
  • 7Niessen K,Karsan A.Notch signaling in the developing cardiovas-cular system[J].Am J Physiol Gell Physiol,2007,293:C1-C11
  • 8Morgan EN,Boyle EM Jr,Yun W,et al.An essential role forNF-κB in the cardioadaptive response to ischemia[J].Ann ThracSurg,1999,68(2):377-382
  • 9Aneia A,Tang WH,Bansilal S,et a1.Diabetic Cardiomyopathy:Insights into pathogenesis,diagnostic challenges and therapeuticoptions[J].Am J Med,2008,121(9):748-757
  • 10Takeuchi M, Yamagishi S. Possible involvement of advanced glycation end-products (AGEs)in the pathogenesis of Alzheimer'S diseasel [J]. Curr Pharm Des,2008,14(10):973-978.

二级参考文献31

  • 1王浩,叶平.过氧化物酶体增殖物激活型受体γ激活剂噻唑烷二酮类药物与心肌缺血再灌注损伤[J].中华老年心脑血管病杂志,2006,8(9):639-640. 被引量:1
  • 2Bates DO, Hillman NJ, Williams B, et al. Regulation of microvascular permeability by vascular endothelial growth factors [J]. J Anat, 2002, 200(6) : 581 -597.
  • 3Arikawa E, Ma RC, Isshiki K, et al. Effects of insulin replacements, inhibitors of angiotensin, and PKCbeta's actions to normalize cardiac gene expression and fuel metabolism in diabetic rats [ J]. Diabetes, 2007, 56(5) : 1410 -1420.
  • 4Xia Z, Kuo KH, Nagareddy PR, et al. N-acetylcysteine attenuates PKCbeta2 overexpression and myocardial hypertrophy in streptozotocin-induced diabetic rats[J].Cardiovasc Res, 2007, 73 (4) : 770 - 782.
  • 5Ishii H, Jirousek MR, Koya D, et al. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor[ J]. Science, 1996, 272 (5262) : 728 - 731.
  • 6Aiello LP, Davis MD, Girach A, et al. Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy [ J ]. Ophthalmology, 2006, 113(12) : 2221 -2230.
  • 7Tuttle KR, Bakris GL, Toto RD, et al. The effect of ruboxistaurin on nephropathy in type 2 diabetes [ J ], Diabetes Care, 2005, 28 ( 11 ) : 2686 - 2690.
  • 8Wu Y, Wu G, Qi x, et al. Protein kinase C beta inhibitor LY333531 attenuates intereellular adhesion molecule-1 and monoeyte ehemotaetie protein-1 expression in the kidney in diabetie rats [ J ]. J Pharmacol Sci, 2006, 101(4) : 335 -343.
  • 9De-Falco E, PorcelliD, TorellaA R,et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells[J]. Blood, 2004, 104(12): 3472-3482.
  • 10FlomenbergN, DiPersio J, CalandraG. Role ofCXCR4 chemokine re-ceptor blockade usingAMD3100 formobilization of autologous hematopoietic progenitor cells [J]. Acta Haemato,l 2005, 114 (4): 198-199.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部